Coterra Energy Inc (CTRA) Stock Analysis

Verdict: AVOID

The CTRA ticker is effectively dead following the $58bn merger with Devon Energy; any capital must now be deployed via DVN.

Investment score: 0/100

Analysis as of

Is Coterra Energy Inc stock worth reviewing? The TradeMates thesis

The TradeMates model rates CTRA as a total AVOID because the security no longer exists as a tradable independent instrument. The merger with Devon Energy (DVN) was completed on May 7, 2026. Data shows the final transaction price near $32.56. While the company's fundamentals until the end of 2025 were stable (FCF yield 8%, D/E 0.23), these are now part of DVN's consolidated financials. Any "investment" attempt in CTRA is a technical impossibility locally.

7-factor investment score

Coterra Energy Inc opportunities and risks

What speaks for CTRA

What speaks against CTRA

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CTRA14.8x3.4x5.8x34.1%22.9%8.0%
DVN12.8x1.7x4.7x22.7%13.5%9.2%
EQT10.4x3.5x5.4x64.0%33.4%11.6%
VG12.9x2.1x6.0x33.4%16.1%-21.5%
TPL52.9x31.8x38.2x97.7%60.0%1.9%
EXE7.1x1.6x3.6x53.4%22.9%12.5%
Peer median12.8x2.1x5.4x53.4%22.9%9.2%

Frequently asked questions about Coterra Energy Inc (CTRA)

Is CTRA stock a good investment?

The TradeMates model rates Coterra Energy Inc as AVOID with an investment score of 0/100. The TradeMates model rates CTRA as a total AVOID because the security no longer exists as a tradable independent instrument. The merger with Devon Energy (DVN) was completed on May 7, 2026. Data shows the final transaction price near $32.56. While the company's fundamentals until the end of 2025 were stable (FCF yield 8%, D/E 0.23), these are now part of DVN's consolidated financials. Any "investment" attempt in CTRA is a technical impossibility locally. This is algorithmic model output, not personal investment advice.

Is CTRA stock a buy?

The TradeMates model verdict for CTRA is AVOID with an investment score of 0/100. Treat this as a model signal to review, not a personal buy recommendation.